Bumper Offer - Urjas oil Just @ Rs. 1
Tolaz DT 5 Tablet (15), a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Schizophrenia. The alternative uses of Tolaz DT 5 Tablet (15) have also been explained below.
The correct dosage of Tolaz DT 5 Tablet (15) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Tolaz DT 5 Tablet (15) as well, which are listed below. Normally, these side effects of Tolaz DT 5 Tablet (15) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Tolaz DT 5 Tablet (15) has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Tolaz DT 5 Tablet (15) related warnings talks about Tolaz DT 5 Tablet (15)'s effects on the liver, heart and kidney.
Tolaz DT 5 Tablet (15) is contraindicated in people with pre-existing medical conditions like Tardive Dyskinesia, Depression as it can result in adverse effects. Other contraindications of Tolaz DT 5 Tablet (15) have been discussed in the sections ahead.
Drug interactions for Tolaz DT 5 Tablet (15) have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Tolaz DT 5 Tablet (15) is not safe while driving, and is is not addictive in nature.
Tolaz DT 5 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Tolaz DT 5 Tablet (15) safe for pregnant women?
Tolaz can have harmful effects in pregnant women. If you experience any discomfort after using Tolaz, then discontinue the use and take your doctor's advice.
Is the use of Tolaz DT 5 Tablet (15) safe during breastfeeding?
Tolaz should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Tolaz DT 5 Tablet (15) on the Kidneys?
Using Tolaz does not have any harmful effects on kidneys.
What is the effect of Tolaz DT 5 Tablet (15) on the Liver?
Tolaz has very mild side effects on the liver.
What is the effect of Tolaz DT 5 Tablet (15) on the Heart?
Tolaz is rarely harmful for the heart.
Tolaz DT 5 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Tolaz DT 5 Tablet (15) unless your doctor advises you to do so -
Is this Tolaz DT 5 Tablet (15) habit forming or addictive?
Tolaz DT 5 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Tolaz DT 5 Tablet (15) can make you feel drowsy.
Is it safe?
Yes, but take Tolaz DT 5 Tablet (15) only as per medical advice.
Is it able to treat mental disorders?
Yes, Tolaz DT 5 Tablet (15) is useful in treating mental disorders.
Interaction between Food and Tolaz DT 5 Tablet (15)
When consumed with certain foods, Tolaz DT 5 Tablet (15) may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tolaz DT 5 Tablet (15)
Consult your doctor before consuming alcohol while taking Tolaz DT 5 Tablet (15) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
